Trial
NCT05983367
A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Inspirna, Inc.
Collaborators
—
Condition
Colorectal Cancer
Intervention
Ompenaclid
Why stopped
At the time of the primary analysis, results did not meet the primary endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-20